Mentice: Mentice: Participates at Redeye Growth Day 2024 (Redeye)

Circio Holding: Circio: Participates at Redeye Growth Day 2024 (Redeye)

Devyser Diagnostics: Devyser: Participates at Redeye Growth Day 2024 (Redeye)

Cantargia: Cantargia: Participates at Redeye Growth Day 2024 (Redeye)

Episurf Medical: Episurf Medical: Participates at Redeye Growth Day 2024 (Redeye)

Medivir: Medivir: Participates at Redeye Growth Day 2024 (Redeye)

Active Biotech: Active Biotech: Participates at Redeye Growth Day 2024 (Redeye)

Moberg Pharma: Moberg Pharma: Participates at Redeye Growth Day 2024 (Redeye)

Cinclus Pharma: Participates at Redeye Growth Day 2024 (Redeye)

NOSIUM: Analyst Group kommenterar Nosiums Q1-rapport (Analyst Group)

Netum Group: IT services sector's 2024 expectations fell slightly in Q1 - revenue expected to remain flat and profitability to rise slightly (Inderes)

Starbreeze: Starbreeze Q1´24: På väg mot ett avgörande andra halvår 2024 (Inderes)

Scibase Holding: SciBase Q1’24 preview: Still modest growth as US ramp-up is gathering speed (Inderes)

ChromoGenics: ChromoGenics: Interview with CEO Fredrik Fränding (Redeye)

Stockpicker: Attendo – Bättre än väntat (Stockpicker)

Calliditas Therapeutics: Calliditas: A SEK 208 cash bid from listed Asahi Kesei (Redeye)

Relais Group: Relais Group: Keeping the wheels spinning (Inderes)

Cantargia: ANALYS Cantargia: Ökat fokus på CAN10 (Analysguiden)

Vimab Group: Vimab: Slutför förvärv - Mangold (Mangold Insight)

Fortnox: Fortnox: Ask questions to Redeye's analyst (Redeye)

Active Biotech: Active Biotech: New Results from Naptumomab (Redeye)

Scandinavian ChemoTech: Scandinavian ChemoTech: Intervju med vd Mohan Frick (Redeye)

Fastator: ANALYS Fastator: Obligationsägarna avgör bolagets fortsatta öde (Analysguiden)

Systemair: ANALYS Systemair: Inför fjärde kvartalet 2024 (Analysguiden)

Scandinavian Enviro Systems: Enviro Q1 2024: In line with expectations (Redeye)

Lipum: Lipum Q1: Initiating preparations for phase II (Redeye)

Alzinova: Alzniova Q1: Extended financial runway (Redeye)

Stayble Therapeutics: Stayble Therapeutics: Rapportkommentar Q1’24 - Kalqyl (Kalqyl)

Endomines: Trending in the right direction - Evli (Evli Research)

Nordic LEVEL Group: Nordic LEVEL Group: Potential för 40-50% EBITDA-CAGR de kommande fem åren (Penser Access)

Elicera Therapeutics: Elicera Therapeutics: CARMA-studien inom räckhåll (Penser Access)

Acroud: Acroud: Små steg i rätt riktning (Penser Access)

ChromoGenics: ChromoGenics: Better off as a private company (Redeye)

AcouSort: AcouSort: Riding the acoustic wave (Redeye)

Tempest Security: Tempest Security: Growth in the double-digits, margins on the rise - SEB (SEB Research)

Fortnox: Fortnox: Raised Long-Term Assumptions Following CMD (Redeye)

MT Højgaard Holding: MT Højgaard Holding - Wins DKK 490m flooding tunnel order with French partner (ABG Sundal Collier)

Freemelt Holding: Freemelt - Commercialisation within reach (ABG Sundal Collier)

SKAKO: SKAKO - Recording of Q1 2024 result presentation (HC Andersen Capital via Inderes)

Sanoma: Sanoma as an Investment | Investor Day May 27, 2024 (Inderes)